Skip to main content
. 2021 Jan 25;9(2):E110–E115. doi: 10.1055/a-1313-6850

Table 1. Characteristics of patients and procedures.

Patients, n. (%) 21
Male, n. (%) 9 (42.9)
Tumor localization:
  • Pancreatic head, n. (%)

14 (66.6)
  • Invasion of the papillary region, n. (%)

3 (14.2)
  • Distal cholangiocarcinoma, n. (%)

3 (14.2)
  • Duodenum infiltration of unknown diagnosis, n. (%)

1 (4.7)
Obstruction site
  • Distal choledocus, n. (%)

20 (95.8)
  • Middle choledocus, n. (%)

1 (4.7)
Cause of failed/unfeasible ERCP
  • Papilla non visualized, n. (%)

12 (57.2)
  • Neoplastic obstruction of the stomach, n. (%)

2 (9.5)
  • Stenosis of the choledocus inaccessible by guidewire, n. (%)

5 (23.8)
  • Other causes, n. (%)

2 (9.5)
LAMS access site positioning
  • Bulb, n. (%)

19 (90.48)
  • Gastric antrum, n. (%)

2 (9.52)

ERCP, endoscopic retrograde cholangiopancreatography; LAMS, lumen-apposing metal stent.